A
APPLIED DNA SCIENCES INC — Investor Relations & Filings
Filings indexed
1,014
across all filing types
Latest filing
2026-04-29
Regulatory Filings
Country
US
United States of America
Listing
US
APDN
Applied DNA Sciences Inc. is a biotechnology company focused on the development and manufacture of DNA-based technologies for genetic medicine. The company's core expertise lies in polymerase chain reaction (PCR) and large-scale, cell-free enzymatic DNA synthesis. Its primary offering is lineaDNA™, a proprietary, linear form of DNA that serves as an alternative to plasmid DNA. This technology is designed for use in advanced therapeutic modalities, including the production of mRNA for vaccines and therapies, as well as for gene and cell therapies. Additionally, the company provides molecular and genomic diagnostic testing services through a clinical laboratory subsidiary.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-04-29 | English | |
| SCHEDULE 13D - BNB PLUS CORP. (0000744452) (Subject) | 2026-03-25 | English | |
| 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-03-24 | English | |
| 4 Filing | 2026-02-13 | English | |
| SCHEDULE 13G Filing | 2026-02-13 | English | |
| 10-Q Filing | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 38812512 | 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-04-29 | English | ||
| 33036132 | SCHEDULE 13D - BNB PLUS CORP. (0000744452) (Subject) | 2026-03-25 | English | ||
| 33035001 | 8-K - BNB PLUS CORP. (0000744452) (Filer) | 2026-03-24 | English | ||
| 23508859 | 4 Filing | 2026-02-13 | English | ||
| 23508852 | SCHEDULE 13G Filing | 2026-02-13 | English | ||
| 23508947 | 10-Q Filing | 2026-02-12 | English | ||
| 32880548 | 8-K - APPLIED DNA SCIENCES INC (0000744452) (Filer) | 2026-02-05 | English | ||
| 18382849 | S-8 Filing | 2026-01-30 | English | ||
| 18382846 | 8-K Filing | 2026-01-22 | English | ||
| 18382848 | SCHEDULE 13G/A Filing | 2026-01-07 | English | ||
|
2025
5 filings
| |||||
| 18382843 | 424B3 Filing | 2025-12-30 | English | ||
| 18382852 | 10-K Filing | 2025-12-22 | English | ||
| 18382842 | S-1/A Filing | 2025-12-22 | English | ||
| 18382853 | 4 Filing | 2025-12-16 | English | ||
| 18382844 | 4 Filing | 2025-12-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
APPLIED DNA SCIENCES INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35347/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35347 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35347 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35347 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35347}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for APPLIED DNA SCIENCES INC (id: 35347)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.